PFE - Pfizer Inc Stock Price, Fair Value and News

$26.25+0.06 (+0.23%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PFE Price Action

Last 7 days

2.1%

Last 30 days

1.4%

Last 90 days

-0.4%

Trailing 12 Months

-5.1%

PFE RSI Chart

PFE Valuation

Market Cap

148.8B

Price/Earnings (Trailing)

21.51

Price/Sales (Trailing)

2.8

EV/EBITDA

11.23

Price/Free Cashflow

15.13

PFE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PFE Fundamentals

PFE Revenue

Revenue (TTM)

53.1B

Rev. Growth (Yr)

722.45%

Rev. Growth (Qtr)

59.55%

PFE Earnings

Earnings (TTM)

6.9B

Earnings Growth (Yr)

3.1K%

Earnings Growth (Qtr)

-65.82%

PFE Profitability

EBT Margin

15.10%

Return on Equity

7.84%

Return on Assets

3.24%

Free Cashflow Yield

6.61%

PFE Investor Care

Dividend Yield

6.44%

Dividend/Share (TTM)

1.69

Shares Dilution (1Y)

0.36%

Diluted EPS (TTM)

1.41

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	24.1B	24.1B	28.3B	53.1B
2023	32.7B	33.0B	23.9B	24.0B
2022	49.9B	34.2B	32.8B	32.6B
2021	46.1B	55.1B	68.9B	60.9B
2020	37.9B	34.5B	32.1B	41.7B
2019	41.0B	40.8B	40.2B	40.9B
2018	52.7B	53.2B	53.4B	40.8B
2017	52.6B	52.3B	52.5B	52.5B
2016	51.0B	52.3B	53.2B	52.8B
2015	49.1B	48.2B	47.9B	48.9B
2014	50.5B	50.3B	50.0B	49.6B
2013	52.7B	51.7B	51.4B	51.6B
2012	59.7B	57.1B	53.5B	55.2B
2011	65.1B	64.4B	65.1B	61.3B
2010	55.0B	61.1B	65.5B	65.2B

Get all data in R, Python etc through our Historical Stock Data APIs

About Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

CEO	Dr. Albert Bourla D.V.M., DVM, Ph.D.
WEBSITE	pfizer.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers General
EMPLOYEES	65535

Pfizer Inc Frequently Asked Questions

What is the ticker symbol for Pfizer Inc? What does PFE stand for in stocks?

PFE is the stock ticker symbol of Pfizer Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Pfizer Inc (PFE)?

As of Fri Mar 21 2025, market cap of Pfizer Inc is 148.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PFE stock?

You can check PFE's fair value in chart for subscribers.

Is Pfizer Inc a good stock to buy?

The fair value guage provides a quick view whether PFE is over valued or under valued. Whether Pfizer Inc is cheap or expensive depends on the assumptions which impact Pfizer Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PFE.

What is Pfizer Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 21 2025, PFE's PE ratio (Price to Earnings) is 21.51 and Price to Sales (PS) ratio is 2.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PFE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Pfizer Inc's stock?

In the past 10 years, Pfizer Inc has provided -0.022 (multiply by 100 for percentage) rate of return.